Skip to Content
A25 / P25
NCODA Oncology and Hematology Meeting Abstracts | Volume 1 | Supplement 1
Publication Date: June 15, 2026

Network for Collaborative Oncology Development and Advancement webinars: a virtual platform for oncology education and engagement

Authors:

Jonathan Rivera, PharmD1

Organization / Company:

1Network for Collaborative Oncology Development & Advancement (NCODA)

NCODA Oncol Hematol Meet Abstr. 2026;1(suppl 1):abstr 25.

Background:

Oncology education is essential to delivering high-quality, patient-centered cancer care. As treatment modalities and care delivery models evolve, timely access to educational resources empowers providers to stay informed and improve outcomes. Webinars, defined as web-based seminars that enable real-time, interactive learning across distances, have proven effective in both professional and academic settings. A meta-analysis of 15 independent sources comparing 716 webinar participants with 698 controls found significant gains in both knowledge and skills among webinar attendees. Network for Collaborative Oncology Development & Advancement (NCODA’s) oncology webinars provide a scalable, virtual platform for delivering timely, practical education to the entire oncology care team. This original research evaluates participation and engagement trends from webinars conducted between October 1, 2024, and August 15, 2025. Live unique viewership was tracked throughout the full period, while attendee characteristics, including United States of America (USA) state, practice site, and clinical credential, were collected beginning March 1, 2025. Feedback data from post-webinar surveys were analyzed quantitatively and qualitatively to assess perceived value, relevance, and satisfaction.

 

Objectives:
  • Identify trends in viewership and feedback on NCODA’s oncology webinar series.
  • Summarize key oncology education themes delivered through NCODA webinars.
  • Demonstrate how webinar engagement data can inform educational planning and partner outreach strategies.

 

Participation & Reach:

Preliminary results show a consistent pattern of engagement, with an adjusted average of ~57 unique attendees per webinar. Attendance peaked at 108 views, with monthly averages ranging from ~38 to ~81. From March to July 2025, webinars reached an average of ~23 USA states and ~39 practice sites per event, spanning academic centers, health systems, and community oncology settings. Audience Composition: Of attendees whose credentials were recorded, nearly 47% were pharmacists, followed by nurses (19.4%), pharmacy technicians (14.7%), and other oncology professionals (16.5%). Representation from advanced practice providers (1.7%) and physicians (1.0%) continues to grow.

 

Engagement & Satisfaction:

Webinars were exceptionally well received: (1) ~75% of attendees reported they “really enjoyed the webinar and would love to attend more”; (2) ~25% found the session “good” and would consider attending again; (3) 0% of respondents across all webinars indicated that the content “didn’t meet expectations.”

 

Clinical Impact:

Across multiple sessions, 90–95% of respondents stated they learned something likely to improve patient care. In confidence-building webinars, 59–78% reported feeling very confident applying what they learned in practice.

 

Resource Needs:

Attendees consistently identified the following tools as most helpful for managing patients on complex therapies: (1) patient education materials, (2) clinical education materials, (3) staff training and competency tools. Additionally, 61.1% of respondents indicated that a Positive Quality Intervention (PQI) resource would be absolutely valuable to their practice.

 

Future Topic Interests:

Frequently requested topics include: (1) emerging oncology therapeutics, (2) biomarkers and emerging oncology therapeutics, (3) oral oncology adherence, (4) oncology policy and legislative updates, (5) precision medicine, (6) hot topics in oncology, (7) disease state spotlight.

 

Conclusions:

Findings reinforce NCODA webinars as a highimpact tool for professional development and partner engagement. The platform’s measurable reach and consistently high satisfaction ratings make it a compelling model for oncology education. Future enhancements will further expand the reach and strategic value of this initiative.

Funding: Not applicable.

A25 / P25